Recruiting

High Protein Diet

Sponsor:

University of Missouri-Columbia

Code:

NCT05235464

Conditions

Atherosclerosis

Eligibility Criteria

Sex: All

Age: 45 - 70+

Healthy Volunteers: Accepted

Interventions

Standard meal

High animal protein meal

High plant protein meal

High plant protein meal with additional leucine

Study Details

Brief summary:

Atherosclerosis is the underlying cause of the majority of cardiovascular diseases, including myocardial infarction and strokes, and results in tremendous morbidity and mortality. A Western-type diet is a major risk factor for atherosclerosis because of the high saturated fat, cholesterol, and refined carbohydrate contents. Dietary strategies to reduce cardiovascular disease burden therefore focus on restriction of saturated fat, cholesterol, and refined carbohydrates whereas "lean" protein intake is recommended and has become popular. However, results from studies conducted in animal models suggest high dietary protein intake is also atherogenic. The investigators' extensive preliminary data in animal models show that dietary protein increases atherosclerotic plaque formation and size and promotes necrotic core formation, a characteristic of rupture-prone plaques. The goal of the current proposal is to provide deeper insights into the relationship between protein intake and the pathogenesis of atherosclerosis by studying the mechanisms involved in protein-mediated atherogenesis and formation of necrotic plaques. The overarching hypothesis is that high protein intake drives atherosclerosis via leucine-mediated mTORC1 signaling in macrophages, which inhibits macrophage mitophagy and aggrephagy and stimulates macrophage proliferation. Furthermore, the investigators hypothesize that proteins from animal sources are more atherogenic than proteins from plant sources, because animal proteins contain more leucine than plant proteins. The investigators will test these hypotheses by using a sophisticated array of experimental strategies, including assays in primary macrophages and human monocyte-derived macrophages and genetically engineered mouse models. In addition, they will begin to translate the results obtained in vitro and in animals to people, and explore approaches to pharmacologically target the pro-atherogenic pathways as novel cardiovascular therapeutics. This proposal represents a paradigm shift in how a Western-type diet affects vascular health which has important implications since many adults in Western societies consume excess protein and dietary protein is heavily marketed for its presumed beneficial health effects.

Conditions

Atherosclerosis

Study ID

NCT05235464

Start date

Mar 13, 2023

Status verified date

Apr, 2026

Completion date

Mar 31, 2028

Anticipated

Primary completion date

Mar 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 45 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • >=45 and <=75 years of age
  • body mass index >=25.0 and <40.0 kg/m2

Exclusion Criteria:

  • <45 and >75 years of age
  • body mass index <25.0 or >39.9 kg/m2
  • plasma triglyceride <125 mg/dl
  • history of or current significant organ system dysfunction
  • allergies or intolerances to meal ingredients
  • use of medications or dietary supplements that could confound the study outcomes
  • engaged in regular structured exercise >150 min per week
  • alcohol use disorder
  • premenopausal women
  • persons who smoke
  • prisoners
  • inability to grant voluntary informed consent

Study Design

Enrollment

24 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Other

Interventions and Outcome Measures

Arms

active comparator: Standard meal

experimental: High animal protein meal

experimental: High plant protein meal

experimental: High plant protein meal with additional leucine

Interventions

Standard meal

Standard meal

High animal protein meal

Meal with high animal protein content

High plant protein meal

Meal with high plant protein content

High plant protein meal with additional leucine

Meal with high plant protein content and additional leucine

Primary outcome measure

  • Monocyte proatherogenic pathway activation [ Time Frame: baseline before meal intake to 3 hours after the meal ]

Central Contacts and Locations

Central contacts

Locations

University of Missouri School of Medicine

Recruiting

Columbia, Missouri, United States, 65212

Contacts

More Information

Sponsor

University of Missouri-Columbia

Last update posted

May 11, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Missouri-Columbia on 2026-05-11.